MSAC
NASDAQ:MSAC
Medicus Sciences Acquisition Corp.
- Stock
Last Close
10.16
17/02 19:47
Volume Today
1.52K
Avg: 51.85K
PE Ratio
13.17
PFCF: -
Dec '20 | Dec '21 | ||
---|---|---|---|
average inventory | |||
average payables | |||
average receivables | |||
book value per share | 8.27 - | ||
capex per share | |||
capex to depreciation | |||
capex to operating cash flow | |||
capex to revenue | |||
cash per share | 0.14 - | ||
days of inventory on hand | |||
days payables outstanding | |||
days sales outstanding | |||
debt to assets | 0.85 - | 0.09 89.65% | |
debt to equity | 5.82 - | 0.10 98.34% | |
dividend yield | |||
earnings yield | 0.02 - | ||
enterprise value | 82.28K - | 98.94M 120,145.19% | |
enterprise value over ebitda | 52.13 - | ||
ev to operating cash flow | -123.91 - | ||
ev to sales | |||
free cash flow per share | -0.08 - | ||
free cash flow yield | -0.01 - | ||
graham net net | -0.66 - | ||
graham number | 5.85 - | ||
income quality | -0.42 - | ||
intangibles to total assets | 0 - | 0 | |
interest coverage | |||
interest debt per share | |||
inventory turnover | |||
invested capital | 4.45 - | ||
market cap | 100.38M - | ||
net current asset value | 18.93K - | -6.69M 35,422.90% | |
net debt to ebitda | -0.76 - | ||
net income per share | 0.18 - | ||
operating cash flow per share | -0.08 - | ||
payables turnover | |||
receivables turnover | |||
research and ddevelopement to revenue | |||
return on tangible assets | 0.02 - | ||
revenue per share | |||
roe | 0.02 - | ||
roic | -0.01 - | ||
sales general and administrative to revenue | |||
shareholders equity per share | 8.27 - | ||
stock based compensation to revenue | |||
tangible asset value | 18.93K - | 85.36M 450,761.47% | |
tangible book value per share | 8.27 - | ||
working capital | 18.93K - | 1.55M 8,076.61% |
All numbers in USD (except ratios and percentages)